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Abstract  
Drug interactions (DIs) is one category of drugs related problems that may affect the clinical outcome of 
patients.  Individuals with chronic kidney disease (CKD) often require multiple classes of drugs being at 
important risk for the development of DIs.The objective ot this study was to determine the factors that influence 
to  potential of drug interaction occurence in patients with CKD at Labuang BajiHospital Makassar. A cross-
sectional study was conducted in April and May 2015. Number of sample was 82 medical records. The sample 
was selected by using a proportioned stratified sampling. The drug interaction was confirmed in the website 
http://www. drugs.com, Tatro Drug Interaction Fact, and Stockley's Drug Interactions. To determine the 
correlation between dependent and independent variables, Spearman’s bivariate correlation (for, age, 
complication, number of drugs used, and lenght of stay) and Mann-Whitney’s Comparative Test (for sex) were 
used. Results of analysis with Spearman Rho test found the three factors that influence to thepotential of drug 
interaction occurence were the number of drugs used (p = 0.000 ; r = 0.60) complications (p = 0.001 ; r = 0.356), 
and lenght of stay (p = 0.000 ; r = 0.405). This study conclusion that number of drugs used were risk factors 
strongly influence to the potential drug interaction occurence.  
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1. Introduction 
The increasing burden of patients with multiple disease conditions, drug therapy has grown more complex. In 
clinical practice, multiple drugs are often combined in the treatment of patients with chronic diseases. These 
associations generally produce drug interactions (DIs) with expected beneficial effects, but in some cases 
undesired outcomes may also occur, such as ineffective treatment and severe adverse events [1,2]. DIs are 
common in clinical practice. DI can be defined as the set of alterations introduced upon the therapeutic effect of 
a given drug stemming from the coadministration of one or more medications [2,3].  
In the last decade, drug-drug interactions are progressive recognized as a very important part of the health 
services in most countries around the world [4]. This situation is caused by more evidence that indicate a great 
negative effects and serious clinical damage from various types of drug-drug interactions [5,6]. Drug-drug 
interactions appears as a cause of drug related problems (DRP) which, when present, produces negative impacts 
on morbidity, mortilitas, toxicity, liver and kidney damage, anemia, increased length of stay and cost of care, 
decreasing quality of life [7,8,9]. 
Drug interactions (DIs) are directly related to factors such as polypharmacy, aging, hepatic metabolism and 
decreased renal function. The incidence of kidney disease has increased significantly in recent years. Patients 
with renal impairment are at high risk against the potential of drug-drug interactions occurrence due to the large 
number and types of drugs they received and the effect of renal disease in drug excretion [10].  
Several studies of drug-drug interactions in patients with chronic kidney disease have been conducted well in 
west and Asia Countries, including Indonesia. A study of drug interaction in patients with chronic kidney 
disease found 76.09% (474 cases) were detected drug interactions [11]. In the study was conducted in Centro 
clinical Hiperdia Minas at Brazil there were ten drugs most often prescribed for patients with CKD: furosemide 
(8.4%), simvastatin (7.1%), losartan (7.1%), acetylsalicylic acid (5 , 2%), captopril (4.7%), hidroklortiazid 
(4.7%), omeprazole (4.5%), enalapril (4.1%), amlodipine (3.3%), and nifedipine (3, 1%) (8). While the result of 
study at Dr. Soedarso Hospital, Indonesiawas foundthe potential of drug interactions occur as much as 20% on 
prescriptions with <5 types of drugs and 46% on prescriptions with  ≥ 5 types of drugs of 240 total sheets 
prescription [12].  
Therefore, the potential of drug interactions that are commonly found in patients with chronic kidney disease 
prescriptions can cause serious adverse event if it is not detected as early as possible. Finally Drug interactions 
need to be considered because it can affect the body's response to treatment [13]. The data obtained from this 
study will be very helpful for the nephrologists in the therapeutic management of patients with CKD effectively. 
Furthermore, the results of this study are very helpful physicians, clinical pharmacists, and nurses to intervene, 
prevent and reduce morbidity due to adverse effects of drug interactions. 
2. Materials and Methods 
This cross-sectional retrospective observational study was carried out at the Labuang BajiHospital 
Makassarcovering the period April and May 2015.The populationof this study wasallofmedical records of 
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inpatiens with CKD. The samples used weremedical recordsof inpatients.The samples wereselectedby using 
Proportioned Stratified Sampling technique. The samplewere determine by using Slovin formula with an error 
rateof 5%. The number of samples given by the formula were82 medical records. 
2.1 Inclusion criteria 
1) Medical records of inpatient in Labuang BajiHospital Makassar for the period of January-December 2014. 
2) The patients of between 15 and 80 years of age. 
3) The patients who were given two or more drugs. 
2.2 Eexclusions criteria 
1) The patients who were given one drug so that drug-drug interaction could not be identified. 
2) Patientswith the strokedisease. 
3) Incomplete records. 
2.3 Data collection 
The data were collected by gathering medical records of pediatric inpatient at Labuang Baji hospital, Makassar 
for the period of January-December 2014. The kinds of data collected were demography, number of drugs used, 
complication, length of stay, and and duration of disease. The drugs written in the medical records were checked 
for the potential drug interaction in website http://www.drugs.com and Tatro Drug Interaction Facts (2014) 
andStockley’s Drug Interaction (2014). 
2.4 Data analysis 
Descriptive analysis was performed using frequencies for categorical variables. Sperman bivariate correlation 
analysis using to determine independent variablesofage, complications, number of drugs used, length of stay, 
and the dependent variable, that is, the number of potential drug interaction occurrences. In addition, Mann-
Whitney of comparative test was used to find out the correlation between sex and potential drug interaction 
occurrences. 
3. Results  
3.1 Characteristics of subjects 
Based on study  has been conducted, 82 medical records of inpatients with CKD were included. Characteristics 
of subjects was shown in Table 1. 
3.2 The factors related to potential drug interaction occurrences 
Based on statistical analyses, the factors-related to potential drug interaction occurrences wasshown in Table2. 
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Table1: Distribution of potential drug interactions occurence of characteristics of subjectsat Labuang Baji 
Makassar Hospital for period January-December 2014 (n = 82) 
 
Variables 
Interaction 
Total Yes No 
n % n % 
Sex 
Male 
Female 
 
16 
27 
 
37.2 
62.8 
 
19 
20 
 
48.7 
51.3 
 
35 
47 
Age (Year) 
< 35 
35-55 
> 55 
 
5 
20 
18 
 
11.6 
46.5 
41.9 
 
5 
22 
12 
 
12.8 
56.4 
30.8 
 
10 
42 
30 
Complication 
uncomplication 
1 
≥ 2 
 
3 
12 
28 
 
7.0 
27.9 
65.1 
 
9 
18 
12 
 
23.1 
46.2 
30.8 
 
12 
30 
40 
number of drugs used 
3 
4-6 
> 6  
 
2 
7 
34 
 
4.7 
16.3 
79.1   
 
16 
15 
8 
 
41.0 
38.5 
20.5 
 
18 
22 
42 
Length of stay (days) 
< 3 
4-6 
> 6 
 
3 
19 
21 
 
7.0 
44.2 
48.8 
 
16 
15 
8 
 
41.0 
38.5 
20.5 
 
19 
34 
29 
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Table 2: The Factors related to potential of drug interactions occurrence of inpatient with CKD at Labuang Baji 
Hospital Makassar for period January-December 2014(n =82) 
 
Variables  
Interaction 
Analysis 
Correlation 
(r) 
Yes No 
n % n % 
Sex 
Male 
Female 
 
15 
26 
 
36.6 
63.4 
 
20 
21 
 
48,8 
51.2 
Mann 
WhitneyCmparative 
test 
( p = 0.296 ) 
 
age (year) 
< 35 
35-55 
> 55 
 
4 
19 
18 
 
9.8 
46.3 
43.9 
 
6 
23 
12 
 
14.6 
56.1 
29.3 
Spearman bivariate 
correlation 
( p = 0.369 ) 0.101 
Complication 
uncomplication 
1 
≥ 2 
 
3 
12 
26 
 
7.3 
29.3 
63.4 
 
9 
18 
14  
 
22.0 
43.9 
34.1 
Spearman bivariate 
correlation 
 ( p = 0.001) 0.356 
Number of drugs used 
3 
4-6 
> 6  
 
1 
8 
32 
 
2.4 
19.5 
78.0   
 
8 
16 
17 
 
19,5 
39.0 
41.5 
Spearman bivariate 
correlation 
 ( p = 0.000 ) 0.600 
Length of stay (days) 
< 3 
4-6 
> 6 
 
3 
16 
22 
 
7.3 
39.0 
53.7 
 
16 
17 
8 
 
39.0 
41.5 
19.5 
Spearman bivariate 
correlation 
 ( p = 0.000 ) 
 
0.405 
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4. Discussion 
The factors related to the potential drug interaction occurrences, according to Spearman,  the potential of drug 
interaction occurence were the number of drugs used (p=0,000), lenght of stay (p=0.000), and complication 
(p=0.000).The number of drugs used has a strong correlation and influence with potential drug interactions 
(r=0.600), while lenght of stay and complication has weak correlation (r=0.405) and (p=0.365). This conclusion 
is confirmed by the standard proposed by [14], which states that r= 0.50-1.00 shows a strong correlation and 
r<0.50 shows weak correlation. On the other hand, the age factor did not show any significant correlation with 
potential drug interactions (p=0.369), which means that the correlation is not significant since p >0,05. 
This studyaccording to by [11. 15. 16] which state that the number of drugs used have correlation with the 
potential drug interaction (p = 0.000), (p=0.006), and (p=0.026). Anotherresearch by [17] also support this study 
that state the patients with greater number of prescribed medications is very high potential for drug interactions 
with AOR = 4.09 and p = 0.000. The study was conducted by [18] also shown the number of drugs sed 
significantly influence topotential drug interaction which the risk of drug interactions increase of 3-5 drugs 
given with OR = 4.74 and for the number of drug given ≥ 6 has OR = 23.03 and p = 0.001. While the study was 
conducted by [19]) wasshown there is a significant correlation between the number one prescription drug with 
potential of drug interactions occurrence with p <0.05 and the drug interactions occurence was increased 6 times 
higher in recipes containing ≥ 5 type of drugs than < 5.  The Mann-Whitney comparative test results showed 
that sex and potential drug interaction occurrences did not show any significant difference (p>0.05), which 
means that sex factor has no connection with drug interaction occurrences. 
5. Conclusion 
Based on the statistical analysis on factors influencing drug interactions at Labuang Baji Hospital, Makassar, it 
can be concluded that: the number of drugs used has a strong influence and correlation with the potential drug 
interactions occurencewhile length of stay and complication has weak correlation. However, age and sex do not 
have any correlation with the potential drug interaction occurrences 
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